NovoCure Ltd — Director's Dealing 2018

Dec 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-12-12

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-12	Ordinary Shares	M	22532	$7.48	Acquired	39619	Direct
2018-12-12	Ordinary Shares	S	21382	$36.00	Disposed	18237	Direct
2018-12-12	Ordinary Shares	S	1150	$36.01	Disposed	17087	Direct
2018-12-12	Ordinary Shares	M	16249	$7.15	Acquired	33336	Direct
2018-12-12	Ordinary Shares	S	15419	$36.00	Disposed	17917	Direct
2018-12-12	Ordinary Shares	S	830	$36.01	Disposed	17087	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-12	Options to Buy Ordinary Shares	$7.48	M	22532	Disposed	2024-02-25	Ordinary Shares (22532)	Direct
2018-12-12	Options to Buy Ordinary Shares	$7.15	M	16249	Disposed	2027-02-21	Ordinary Shares (16249)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.

F2: Options exercised were fully vested as of the date hereof.